Creating a roadmap is critical to navigating the challenges that come with dementia. Being Patient sat down with Bree Baldwin, aging life care manager…
Now under review, the drug pimavanserin may become the first FDA-approved treatment for dementia-related psychosis. Roughly 2.4 million Americans experience symptoms of dementia-related psychosis,…
For families including those with loved ones who have dementia, navigating the system of conservatorship can be daunting. In November 2020, a Los Angeles…
Shedding further light on the mystery of Alzheimer’s pathology, a new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia…
New research paves the way for a future in which concussions — which are often missed — could be detected on the spot with…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…
“There are one too many similarities for this to be a coincidence,” says a recent Popular Mechanics review of new brain research. We’ve got…